The potential of serum prostate-specific antigen as a predictor of clinical response in patients with lower urinary tract symptoms and benign prostatic hyperplasia.

Abstract

BJU InternationalVolume 93, Issue s1 p. 21-26 The potential of serum prostate-specific antigen as a predictor of clinical response in patients with lower urinary tract symptoms and benign prostatic hyperplasia C.G. Roehrborn, Corresponding Author C.G. Roehrborn Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USAProf. C. G. Roehrborn, Department of Urology, UT Southwestern Medical Center, 5323, Harry Hines Blvd J8-148, Dallas, Texas 75390–9110, USA. e-mail: Claus.Roehrborn@UTSouthwestern.eduSearch for more papers by this author C.G. Roehrborn, Corresponding Author C.G. Roehrborn Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USAProf. C. G. Roehrborn, Department of Urology, UT Southwestern Medical Center, 5323, Harry Hines Blvd J8-148, Dallas, Texas 75390–9110, USA. e-mail: Claus.Roehrborn@UTSouthwestern.eduSearch for more papers by this author First published: 17 February 2004 https://doi.org/10.1111/j.1464-410X.2003.04636.xCitations: 13Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume93, Issues1March 2004Pages 21-26 RelatedInformation